Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

Market Cap	62.33B
Revenue (ttm)	4.27B
Net Income (ttm)	308.94M
Shares Out	1.11B
EPS (ttm)	0.27
PE Ratio	205.48
Forward PE	118.71
Dividend	0.42 (0.74%)
Ex-Dividend Date	n/a

Volume	3,981,770
Average Volume	4,518,515
Open	55.46
Previous Close	56.68
Day's Range	55.46 - 59.00
52-Week Range	29.13 - 62.65
Beta	-0.07
RSI	58.36
Earnings Date	Oct 29, 2025

About SHE:002653

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. The company offers pharmaceutical products in the areas of anesthesia and analgesia, diabetes mellitus and complications, tumor, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory, narcotic analgesics, endocrine system, enteral parenteral, nutrition, neuropsychiatric, cardiovascular, digestive liver, and other diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 5,337
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002653

Financial Performance

In 2024, SHE:002653's revenue was 3.72 billion, an increase of 10.92% compared to the previous year's 3.36 billion. Earnings were 395.46 million, an increase of 34.00%.